108 related articles for article (PubMed ID: 24023438)
1. Successful treatment of laser induced hypopigmentation with narrowband ultraviolet B targeted phototherapy.
Mysore V; Anitha B; Hosthota A
J Cutan Aesthet Surg; 2013 Apr; 6(2):117-9. PubMed ID: 24023438
[TBL] [Abstract][Full Text] [Related]
2. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
Ustuner P; Balevi A; Ozdemir M
J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
[TBL] [Abstract][Full Text] [Related]
3. Hypopigmentation Induced by Frequent Low-Fluence, Large-Spot-Size QS Nd:YAG Laser Treatments.
Wong Y; Lee SS; Goh CL
Ann Dermatol; 2015 Dec; 27(6):751-5. PubMed ID: 26719647
[TBL] [Abstract][Full Text] [Related]
4. A split-tattoo randomized Q-switched neodymium-doped yttrium-aluminium-garnet laser trial comparing the efficacy of a novel three-pass, one-session method with a conventional method in the treatment of blue/black tattoos in darker skin types.
Narayanan A; Bhari N; Sreenivas V; Sharma VK; Sethuraman G
Clin Exp Dermatol; 2022 Jan; 47(1):125-128. PubMed ID: 34236705
[TBL] [Abstract][Full Text] [Related]
5. A Retrospective Study on the Characteristics of Treating Nevus of Ota by 1064-nm Q-switched Neodymium-doped Yttrium Aluminum Garnet Laser.
Liu Y; Zeng W; Geng S
Indian J Dermatol; 2016; 61(3):347. PubMed ID: 27293272
[TBL] [Abstract][Full Text] [Related]
6. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
[TBL] [Abstract][Full Text] [Related]
7. A low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminium garnet laser for the treatment of café-au-lait macules.
Kim HR; Ha JM; Park MS; Lee Y; Seo YJ; Kim CD; Lee JH; Im M
J Am Acad Dermatol; 2015 Sep; 73(3):477-83. PubMed ID: 26169691
[TBL] [Abstract][Full Text] [Related]
8. A Case of Facial Partial Unilateral Lentiginosis Treated with Low-Fluence 1,064 nm Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser.
Kim EH
Case Rep Dermatol; 2017; 9(2):30-34. PubMed ID: 28690515
[TBL] [Abstract][Full Text] [Related]
9. Q-Switched Neodymium-Doped Yttrium Aluminum Garnet laser therapy for pigmented skin lesions: efficacy and safety.
Karn D; K C S; Amatya A; Razouria EA; Timalsina M; Suwal A
Kathmandu Univ Med J (KUMJ); 2012; 10(38):46-50. PubMed ID: 23132475
[TBL] [Abstract][Full Text] [Related]
10. Beneficial Effect of Low Fluence 1,064 nm Q-Switched Neodymium:Yttrium-Aluminum-Garnet Laser in the Treatment of Senile Lentigo.
Nam JH; Kim HS; Lee GY; Kim WS
Ann Dermatol; 2017 Aug; 29(4):427-432. PubMed ID: 28761290
[TBL] [Abstract][Full Text] [Related]
11. Combination of 1064-nm Q-switched neodymium-doped yttrium-aluminum-garnet laser with Modified Jessner's peel for the treatment of Nevus of Ota: A case series of seven patients.
Raj C; Dixit N; Debata I; Hassanandani T; Behera D; Panda M
Dermatol Ther; 2020 Nov; 33(6):e14384. PubMed ID: 33089642
[TBL] [Abstract][Full Text] [Related]
12. In vivo trial comparing patients' tolerance of Q-switched Alexandrite (QS Alex) and Q-switched neodymium:yttrium-aluminum-garnet (QS Nd:YAG) lasers in the treatment of nevus of Ota.
Chan HH; King WW; Chan ES; Mok CO; Ho WS; Van Krevel C; Lau WY
Lasers Surg Med; 1999; 24(1):24-8. PubMed ID: 10037348
[TBL] [Abstract][Full Text] [Related]
13. Intense Pulsed Light and Q-Switched 1,064-nm Neodymium-Doped Yttrium Aluminum Garnet Laser Treatment for the Scarring Lesion of Discoid Lupus Erythematosus.
Byun YS; Son JH; Cho YS; Chung BY; Cho HJ; Park CW; Kim HO
Ann Dermatol; 2017 Jun; 29(3):331-333. PubMed ID: 28566911
[TBL] [Abstract][Full Text] [Related]
14. Use of the 532-nm Q-switched neodymium-doped yttrium aluminum garnet laser for the treatment of recalcitrant repigmentation in vitiligo.
Modi K; Mohammad TF; Hamzavi IH
JAAD Case Rep; 2018 Jul; 4(6):612-614. PubMed ID: 30003131
[No Abstract] [Full Text] [Related]
15. Low-fluence Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser for the treatment of facial partial unilateral lentiginosis in Koreans.
Lee Y; Choi EH; Lee SW
Dermatol Surg; 2012 Jan; 38(1):31-7. PubMed ID: 22093176
[TBL] [Abstract][Full Text] [Related]
16. A retrospective analysis of complications in the treatment of nevus of Ota with the Q-switched alexandrite and Q-switched Nd:YAG lasers.
Chan HH; Leung RS; Ying SY; Lai CF; Kono T; Chua JK; Ho WS
Dermatol Surg; 2000 Nov; 26(11):1000-6. PubMed ID: 11096383
[TBL] [Abstract][Full Text] [Related]
17. The removal of cutaneous pigmented lesions with the Q-switched ruby laser and the Q-switched neodymium: yttrium-aluminum-garnet laser. A comparative study.
Tse Y; Levine VJ; McClain SA; Ashinoff R
J Dermatol Surg Oncol; 1994 Dec; 20(12):795-800. PubMed ID: 7798410
[TBL] [Abstract][Full Text] [Related]
18. 1064 nm Q-switched Nd:YAG laser for the treatment of Argyria: a systematic review.
Griffith RD; Simmons BJ; Bray FN; Falto-Aizpurua LA; Yazdani Abyaneh MA; Nouri K
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2100-3. PubMed ID: 25845405
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acquired bilateral nevus of ota-like macules (Hori's nevus) with a combination of the 532 nm Q-Switched Nd:YAG laser followed by the 1,064 nm Q-switched Nd:YAG is more effective: prospective study.
Ee HL; Goh CL; Khoo LS; Chan ES; Ang P
Dermatol Surg; 2006 Jan; 32(1):34-40. PubMed ID: 16393596
[TBL] [Abstract][Full Text] [Related]
20. Neodymium-doped yttrium aluminium garnet (Nd:YAG) 1064-nm picosecond laser vs. Nd:YAG 1064-nm nanosecond laser in tattoo removal: a randomized controlled single-blind clinical trial.
Pinto F; Große-Büning S; Karsai S; Weiß C; Bäumler W; Hammes S; Felcht M; Raulin C
Br J Dermatol; 2017 Feb; 176(2):457-464. PubMed ID: 27518129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
